Orion Pharma Statistics

Total Valuation

Orion Pharma has a market cap or net worth of BDT 8.85 billion. The enterprise value is 33.17 billion.

Market Cap	8.85B
Enterprise Value	33.17B

Important Dates

The last earnings date was Tuesday, November 26, 2024.

Earnings Date	Nov 26, 2024
Ex-Dividend Date	Dec 5, 2024

Share Statistics

Orion Pharma has 234.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	234.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	25.83%
Owned by Institutions (%)	n/a
Float	84.32M

Valuation Ratios

The trailing PE ratio is 44.95.

PE Ratio	44.95
Forward PE	n/a
PS Ratio	1.02
PB Ratio	0.42
P/TBV Ratio	0.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.23, with an EV/FCF ratio of -49.79.

EV / Earnings	168.56
EV / Sales	3.83
EV / EBITDA	22.23
EV / EBIT	39.58
EV / FCF	-49.79

Financial Position

The company has a current ratio of 2.07, with a Debt / Equity ratio of 1.02.

Current Ratio	2.07
Quick Ratio	1.74
Debt / Equity	1.02
Debt / EBITDA	15.47
Debt / FCF	-34.47
Interest Coverage	1.92

Financial Efficiency

Return on equity (ROE) is 0.98% and return on invested capital (ROIC) is 1.15%.

Return on Equity (ROE)	0.98%
Return on Assets (ROA)	0.95%
Return on Capital (ROIC)	1.15%
Revenue Per Employee	2.74M
Profits Per Employee	62,272
Employee Count	3,160
Asset Turnover	0.16
Inventory Turnover	3.38

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.51% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-52.51%
50-Day Moving Average	38.12
200-Day Moving Average	58.54
Relative Strength Index (RSI)	46.92
Average Volume (20 Days)	1,203,860

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orion Pharma had revenue of BDT 8.66 billion and earned 196.78 million in profits. Earnings per share was 0.84.

Revenue	8.66B
Gross Profit	2.13B
Operating Income	829.34M
Pretax Income	391.99M
Net Income	196.78M
EBITDA	1.47B
EBIT	829.34M
Earnings Per Share (EPS)	0.84

Full Income Statement

Balance Sheet

The company has 158.26 million in cash and 22.96 billion in debt, giving a net cash position of -22.79 billion or -97.38 per share.

Cash & Cash Equivalents	158.26M
Total Debt	22.96B
Net Cash	-22.79B
Net Cash Per Share	-97.38
Equity (Book Value)	22.57B
Book Value Per Share	89.88
Working Capital	8.99B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.11 billion and capital expenditures -1.78 billion, giving a free cash flow of -666.14 million.

Operating Cash Flow	1.11B
Capital Expenditures	-1.78B
Free Cash Flow	-666.14M
FCF Per Share	-2.85

Full Cash Flow Statement

Margins

Gross margin is 24.65%, with operating and profit margins of 9.58% and 2.27%.

Gross Margin	24.65%
Operating Margin	9.58%
Pretax Margin	4.53%
Profit Margin	2.27%
EBITDA Margin	16.93%
EBIT Margin	9.58%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 2.65%.

Dividend Per Share	1.00
Dividend Yield	2.65%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	139.49%
Buyback Yield	n/a
Shareholder Yield	2.65%
Earnings Yield	2.22%
FCF Yield	-7.53%

Dividend Details

Stock Splits

The last stock split was on May 27, 2013. It was a forward split with a ratio of 1.2.

Last Split Date	May 27, 2013
Split Type	Forward
Split Ratio	1.2

Scores

Orion Pharma has an Altman Z-Score of 0.93. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.93
Piotroski F-Score	n/a